Description:

Depression. Suicide. Substance abuse. Alcoholism. PTSD. Psychedelic therapy often succeeds where traditional treatments fail. What’s going on in the brain that facilitates this? And what’s the status of current FDA-approved clinical trials and the road to legal therapy.

Join Rick Doblin, MAPS Founder (Multidisciplinary Association for Psychedelic Studies), combat photojournalist Michael Christopher Brown and photographer/anthropologist Joshua Cogan for a wide-ranging discussion on the promise and future of psychedelic therapy.